Author

Chung Hoow Kok

Observed names: C H Kok, C. H. Kok, C. Kok, C.H. Kok, Chung Hoow Kok, Chung H Kok, Chung H. Kok, Chung How Kok, Chung Kok, Kok, C., Kok, Chung

Institutions: South Australia Pathology, University of South Australia, South Australian Health and Medical Research Institute, Centre for Cancer Biology, Adelaide University, The University of Adelaide

Observed institutions: South Australia Pathology, Mayo Clinic, University of South Australia, Basil Hetzel Institute, Women's & Children's Health Research Institute, Queen Elizabeth Hospital, South Australian Health and Medical Research Institute, Centre for Cancer Biology, Australasian Leukaemia and Lymphoma Group, Hanson Institute, Adelaide University, The University of Adelaide

ORCID: 0000-0002-3181-7852

Observed ORCID: 0000-0002-3181-7852

OpenAlex ID: A5061012183

Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia

2011 · Christopher N Hahn, Chan-Eng Chong, et al. · Nature Genetics · 606

Ecotopic viral integration site 1 (EVI1) regulates multiple cellular processes important for cancer and is a synergistic partner for FOS protein in invasive tumors

2012 · Emilie A. Bard-Chapeau, Justin Jeyakani, et al. · Proceedings of the National Academy of Sciences · 97

Successful treatment‐free remission in chronic myeloid leukaemia and its association with reduced immune suppressors and increased natural killer cells

2020 · Yazad D. Irani, Amy Hughes, et al. · British Journal of Haematology · 79

PDF

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

2018 · on behalf of the Australasian Leukaemia and Lymphoma Group (ALLG), David M. Ross, et al. · Leukemia · 79

High prevalence of relapse in children with Philadelphia-like acute lymphoblastic leukemia despite risk-adapted treatment

2017 · Susan L. Heatley, Teresa Sadras, et al. · Haematologica · 61

Expression profiling of a hemopoietic cell survival transcriptome implicates osteopontin as a functional prognostic factor in AML

2009 · Jason A. Powell, Daniel Thomas, et al. · Blood · 57

PDF

HoxA9 regulated Bcl-2 expression mediates survival of myeloid progenitors and the severity of HoxA9-dependent leukemia

2013 · Gabriela Brumatti, Marika Salmanidis, et al. · Oncotarget · 55

PDF

TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy

2016 · E Nievergall, J Reynolds, et al. · Leukemia · 50

Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission

2019 · Ilaria S. Pagani, Phuong Dang, et al. · Leukemia · 48

SAMSN1 Is a Tumor Suppressor Gene in Multiple Myeloma

2014 · Jacqueline E. Noll, Duncan R. Hewett, et al. · Neoplasia · 48

PDF

TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

2023 · Mithun Vinod Shah, Elizabeth Ngoc Hoa Tran, et al. · Blood Cancer Journal · 47

PDF

Genetic regulators of myelopoiesis and leukemic signaling identified by gene profiling and linear modeling

2006 · Anna L Brown, Christopher R Wilkinson, et al. · Journal of Leukocyte Biology · 47

TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype

2022 · Devendra Hiwase, Christopher Hahn, et al. · Blood · 43

PDF

PTTG1 expression is associated with hyperproliferative disease and poor prognosis in multiple myeloma

2015 · Jacqueline E. Noll, Kate Vandyke, et al. · Journal of Hematology & Oncology · 43

PDF

Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia

2021 · Ing S. Tiong, Richard Dillon, et al. · Blood Advances · 40

PDF

Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib

2019 · Chung H. Kok, David T. Yeung, et al. · Blood Advances · 40

PDF

Pre-B acute lymphoblastic leukaemia recurrent fusion, EP300-ZNF384, is associated with a distinct gene expression

2018 · Barbara J. McClure, Susan L. Heatley, et al. · British Journal of Cancer · 39

PDF

COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study

2020 · Delphine Rea, Michael J. Mauro, et al. · Blood · 29

The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation

2011 · Anna L. Brown, Diana G. Salerno, et al. · Differentiation · 29

GADD45A methylation predicts poor overall survival in acute myeloid leukemia and is associated with IDH1/2 and DNMT3A mutations

2012 · M Perugini, D G Iarossi, et al. · Leukemia · 27

The granulocyte-associated transcription factor Krüppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia

2011 · Sonya M. Diakiw, Chung H. Kok, et al. · Leukemia Research · 27

Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions

2017 · Teresa Sadras, Susan L. Heatley, et al. · Cancer Letters · 26

Integrated Bioinformatics Analysis Reveals Key Candidate Genes and Pathways Associated With Clinical Outcome in Hepatocellular Carcinoma

2020 · Yubin Li, Runzhe Chen, et al. · Frontiers in Genetics · 25

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention

2023 · Naranie Shanmuganathan, Carol Wadham, et al. · Haematologica · 24

PDF

A senescence stress secretome is a hallmark of therapy-related myeloid neoplasm stromal tissue occurring soon after cytotoxic exposure

2022 · Monika M. Kutyna, Chung Hoow Kok, et al. · Leukemia · 24

PDF

Works count: 150

Citation count: 2,257

H-index: 24

I10-index: 50